+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Johnson

Company Analysis: Johnson & Johnson - Product Thumbnail Image

Company Analysis: Johnson & Johnson

  • Company Profile
  • January 2021
  • 62 Pages
Johnson & Johnson Company Analysis - Product Thumbnail Image

Johnson & Johnson Company Analysis

  • Company Profile
  • July 2020
  • 62 Pages
Johnson & Johnson - Digital Transformation Strategies - Product Thumbnail Image

Johnson & Johnson - Digital Transformation Strategies

  • Company Profile
  • September 2023
  • 31 Pages
From
Company Analysis 2023 - Johnson and Johnson Services, Inc. - Product Thumbnail Image

Company Analysis 2023 - Johnson and Johnson Services, Inc.

  • Report
  • October 2023
  • 15 Pages
  • Global
From
Johnson and Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Johnson and Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 86 Pages
From
Prezista (darunavir; Johnson & Johnson) Drug Overview 2019 - Product Thumbnail Image

Prezista (darunavir; Johnson & Johnson) Drug Overview 2019

  • Report
  • June 2019
  • 21 Pages
  • Global
Johnson and Johnson (JNJ:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement, Market Size and Growth Forecasts - Product Thumbnail Image

Johnson and Johnson (JNJ:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement, Market Size and Growth Forecasts

  • Company Profile
  • April 2024
  • 86 Pages
From
Symtuza ([darunavir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)]; Johnson & Johnson) Drug Overview 2019 - Product Thumbnail Image

Symtuza ([darunavir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)]; Johnson & Johnson) Drug Overview 2019

  • Report
  • June 2019
  • 16 Pages
  • Global
Odefsey ([rilpivirine + emtricitabine + tenofovir alafenamide (TAF)]; Gilead/Johnson & Johnson) Drug Overview 2019 - Product Thumbnail Image

Odefsey ([rilpivirine + emtricitabine + tenofovir alafenamide (TAF)]; Gilead/Johnson & Johnson) Drug Overview 2019

  • Report
  • June 2019
  • 15 Pages
  • Global
Juluca ([dolutegravir + rilpivirine]; ViiV Healthcare/Johnson & Johnson) Drug Overview 2019 - Product Thumbnail Image

Juluca ([dolutegravir + rilpivirine]; ViiV Healthcare/Johnson & Johnson) Drug Overview 2019

  • Report
  • June 2019
  • 14 Pages
  • Global
Complera ([rilpivirine + emtricitabine + tenofovir disoproxil fumarate (TDF)]; Gilead/Johnson & Johnson) Drug Overview 2019 - Product Thumbnail Image

Complera ([rilpivirine + emtricitabine + tenofovir disoproxil fumarate (TDF)]; Gilead/Johnson & Johnson) Drug Overview 2019

  • Report
  • June 2019
  • 15 Pages
  • Global
Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • April 2024
  • 99 Pages
From
Johnson and Johnson - Enterprise Tech Ecosystem Series - Product Thumbnail Image

Johnson and Johnson - Enterprise Tech Ecosystem Series

  • Company Profile
  • October 2021
  • 27 Pages
From
Johnson & Johnson Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Johnson & Johnson Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • June 2024
  • 50 Pages
From
Johnson & Johnson Inc in Eyewear (World) - Product Thumbnail Image

Johnson & Johnson Inc in Eyewear (World)

  • Company Profile
  • January 2023
  • 36 Pages
From
S.C. Johnson & Son, Inc. - Company Overview and Analysis, 2023 Update - Product Thumbnail Image

S.C. Johnson & Son, Inc. - Company Overview and Analysis, 2023 Update

  • Company Profile
  • July 2023
  • 15 Pages
From
Johnson & Johnson Inc in Beauty and Personal Care (World) - Product Thumbnail Image

Johnson & Johnson Inc in Beauty and Personal Care (World)

  • Company Profile
  • September 2022
  • 46 Pages
From
COVID-19 Impact on Johnson and Johnson Services Inc - Product Thumbnail Image

COVID-19 Impact on Johnson and Johnson Services Inc

  • Company Profile
  • February 2021
  • 18 Pages
From
Comprehensive Report on Johnson & Johnson, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Johnson & Johnson, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Johnson Outdoors Inc (JOUT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Johnson Outdoors Inc (JOUT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • December 2023
  • 76 Pages
From
Loading Indicator